Merck & Co., Inc.
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/30220% above fair value
$133.72+0.91 (+0.69%)
Close on Nov 20, 2026Market cap $329.91BP/E 107.0Yield 2.45%
Merck Payments on Debt: -$5M in Q2 2026.
Latest, Q2 2026
-5
Period ended Jun 30, 2026
Change on a year earlier
–
0 in Q2 2025
History
68 quarters
Since Q3 2008
Sources
64
Documents cited below
Where the Q2 2026 figure comes from
Calculated from reported figures: quarter = year-to-date − previous year-to-date (cash flow statement)
Source: Form 10-Q (filed 2026-08-07) ↗
Reported in Postgres DB financial_values.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Merck Payments on Debt ($M), quarterly Q3 2008–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db-cf-d-rep
See every metric in the Merck KPI table. Data updated Oct 26, 2026.
See a number that looks wrong?